- 1.
Eskild A, Skau I, Haavaldsen C et al. Teknologi redder fosterliv. Tidsskr Nor Legeforen 2021; 141. doi: 10.4045/tidsskr.21.0256. [PubMed][CrossRef]
- 2.
FHI. 40 prosent av kvinner som blir gravide i Norge er overvektige eller har fedme rett før svangerskapets start. https://www.fhi.no/nyheter/2023/40-prosent-av-kvinner-som-blir-gravide-i-norge-er-overvektige-eller-har-fedme-rett-for-svangerskapets-start/ Accessed 18.1.2024.
- 3.
Salvesen KAB, Staff AC. Ny og nyttig screening for preeklampsirisiko. Tidsskr Nor Legeforen 2023; 143. doi: 10.4045/tidsskr.22.0784. [PubMed][CrossRef]
- 4.
Salomon LJ, Alfirevic Z, Berghella V et al. ISUOG Practice Guidelines (updated): performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2022; 59: 840–56. [PubMed][CrossRef]
- 5.
Ebbing C, Kiserud T, Johnsen SL et al. Prevalence, risk factors and outcomes of velamentous and marginal cord insertions: a population-based study of 634,741 pregnancies. PLoS One 2013; 8. doi: 10.1371/journal.pone.0070380. [PubMed][CrossRef]
- 6.
Ebbing C, Rasmussen S, Kessler J et al. Association of placental and umbilical cord characteristics with cerebral palsy: national cohort study. Ultrasound Obstet Gynecol 2023; 61: 224–30. [PubMed][CrossRef]
- 7.
Ebbing C, Kiserud T, Johnsen SL et al. Third stage of labor risks in velamentous and marginal cord insertion: a population-based study. Acta Obstet Gynecol Scand 2015; 94: 878–83. [PubMed][CrossRef]
- 8.
Siargkas A, Tsakiridis I, Pachi C et al. Impact of velamentous cord insertion on perinatal outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2023; 5. doi: 10.1016/j.ajogmf.2022.100812. [PubMed][CrossRef]
- 9.
Toubas PL, Silverman NH, Heymann MA et al. Cardiovascular effects of acute hemorrhage in fetal lambs. Am J Physiol 1981; 240: H45–8. [PubMed]
- 10.
Oyelese Y, Javinani A, Shamshirsaz AA. Vasa Previa. Obstet Gynecol 2023; 142: 503–18. [PubMed][CrossRef]
- 11.
Conyers S, Oyelese Y, Javinani A et al. Incidence and causes of perinatal death in prenatally diagnosed vasa previa: a systematic review and meta-analysis. Am J Obstet Gynecol 2024; 230: 58–65. [PubMed][CrossRef]
- 12.
Chmait RH, Monson MA, Chon AH et al. Third-trimester fetoscopic ablation therapy for types II and III vasa previa. Am J Obstet Gynecol 2024; 230: 87.e1–9. [PubMed][CrossRef]
- 13.
Gross A, Markota Ajd B, Specht C et al. Systematic screening for vasa previa at the 20-week anomaly scan. Acta Obstet Gynecol Scand 2021; 100: 1694–9. [PubMed][CrossRef]
()